| 1 | fat-soluble vitamin catabolic process (GO:0042363) | 9.95024635 |
| 2 | vitamin catabolic process (GO:0009111) | 9.95024635 |
| 3 | regulation of female receptivity (GO:0045924) | 9.41360104 |
| 4 | mature B cell differentiation involved in immune response (GO:0002313) | 8.92825568 |
| 5 | female mating behavior (GO:0060180) | 8.15807528 |
| 6 | negative regulation of hematopoietic progenitor cell differentiation (GO:1901533) | 7.07009418 |
| 7 | mature B cell differentiation (GO:0002335) | 6.82007760 |
| 8 | phospholipase C-activating dopamine receptor signaling pathway (GO:0060158) | 6.73451644 |
| 9 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 6.17231948 |
| 10 | detection of light stimulus involved in visual perception (GO:0050908) | 5.75425164 |
| 11 | detection of light stimulus involved in sensory perception (GO:0050962) | 5.75425164 |
| 12 | synaptic transmission, dopaminergic (GO:0001963) | 5.63827008 |
| 13 | cellular glucuronidation (GO:0052695) | 5.40008530 |
| 14 | lipoxygenase pathway (GO:0019372) | 5.36990372 |
| 15 | protein targeting to vacuole (GO:0006623) | 5.30687259 |
| 16 | protein targeting to lysosome (GO:0006622) | 5.30687259 |
| 17 | establishment of protein localization to vacuole (GO:0072666) | 5.30687259 |
| 18 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 5.23461127 |
| 19 | response to gravity (GO:0009629) | 5.20656575 |
| 20 | glucuronate metabolic process (GO:0019585) | 5.08437660 |
| 21 | uronic acid metabolic process (GO:0006063) | 5.08437660 |
| 22 | polarized epithelial cell differentiation (GO:0030859) | 5.03132860 |
| 23 | skeletal muscle adaptation (GO:0043501) | 4.91612030 |
| 24 | embryonic heart tube development (GO:0035050) | 4.88195830 |
| 25 | regulation of inositol phosphate biosynthetic process (GO:0010919) | 4.86495947 |
| 26 | morphogenesis of an endothelium (GO:0003159) | 4.84653001 |
| 27 | endothelial tube morphogenesis (GO:0061154) | 4.84653001 |
| 28 | negative regulation of oxidoreductase activity (GO:0051354) | 4.82972268 |
| 29 | striated muscle atrophy (GO:0014891) | 4.76768447 |
| 30 | positive regulation of cAMP-mediated signaling (GO:0043950) | 4.74841742 |
| 31 | muscle filament sliding (GO:0030049) | 4.61403009 |
| 32 | actin-myosin filament sliding (GO:0033275) | 4.61403009 |
| 33 | coenzyme catabolic process (GO:0009109) | 4.59892014 |
| 34 | lymphangiogenesis (GO:0001946) | 4.54860258 |
| 35 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 4.52709760 |
| 36 | pantothenate metabolic process (GO:0015939) | 4.51924761 |
| 37 | long term synaptic depression (GO:0060292) | 4.31487086 |
| 38 | glycosphingolipid biosynthetic process (GO:0006688) | 4.30578546 |
| 39 | regulation of MHC class II biosynthetic process (GO:0045346) | 4.29978108 |
| 40 | GTP biosynthetic process (GO:0006183) | 4.22298658 |
| 41 | neuronal action potential (GO:0019228) | 4.20383624 |
| 42 | regulation of sensory perception of pain (GO:0051930) | 4.20030904 |
| 43 | regulation of sensory perception (GO:0051931) | 4.20030904 |
| 44 | ATP synthesis coupled proton transport (GO:0015986) | 4.19167672 |
| 45 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 4.19167672 |
| 46 | muscle atrophy (GO:0014889) | 4.10749040 |
| 47 | protein localization to vacuole (GO:0072665) | 4.07418642 |
| 48 | protein localization to lysosome (GO:0061462) | 4.07418642 |
| 49 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.02128693 |
| 50 | tissue regeneration (GO:0042246) | 3.99292308 |
| 51 | regulation of germinal center formation (GO:0002634) | 3.87402479 |
| 52 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.83525248 |
| 53 | DNA deamination (GO:0045006) | 3.69583375 |
| 54 | actin-mediated cell contraction (GO:0070252) | 3.65036385 |
| 55 | transmission of nerve impulse (GO:0019226) | 3.62294348 |
| 56 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.61699687 |
| 57 | primary amino compound metabolic process (GO:1901160) | 3.59063325 |
| 58 | UTP biosynthetic process (GO:0006228) | 3.58016708 |
| 59 | collecting duct development (GO:0072044) | 3.57595287 |
| 60 | protein polyglutamylation (GO:0018095) | 3.54116832 |
| 61 | pericardium development (GO:0060039) | 3.50421956 |
| 62 | positive regulation of chemokine secretion (GO:0090197) | 3.47749225 |
| 63 | positive regulation of macrophage derived foam cell differentiation (GO:0010744) | 3.43671656 |
| 64 | venous blood vessel morphogenesis (GO:0048845) | 3.40577751 |
| 65 | positive regulation of phosphatase activity (GO:0010922) | 3.38140706 |
| 66 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.36217879 |
| 67 | positive regulation of macrophage differentiation (GO:0045651) | 3.34010918 |
| 68 | nonmotile primary cilium assembly (GO:0035058) | 3.27417355 |
| 69 | UTP metabolic process (GO:0046051) | 3.26063129 |
| 70 | regulation of macrophage chemotaxis (GO:0010758) | 3.20852031 |
| 71 | regulation of megakaryocyte differentiation (GO:0045652) | 3.18374386 |
| 72 | response to muscle activity (GO:0014850) | 3.18149260 |
| 73 | regulation of skeletal muscle contraction (GO:0014819) | 3.17596314 |
| 74 | B cell activation involved in immune response (GO:0002312) | 3.15484894 |
| 75 | membrane depolarization during action potential (GO:0086010) | 3.15472338 |
| 76 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.12937457 |
| 77 | endothelial cell development (GO:0001885) | 3.12177156 |
| 78 | multicellular organismal reproductive behavior (GO:0033057) | 3.11123029 |
| 79 | regulation of mesoderm development (GO:2000380) | 3.03965016 |
| 80 | basic amino acid transport (GO:0015802) | 3.03221112 |
| 81 | indolalkylamine metabolic process (GO:0006586) | 2.99900187 |
| 82 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.97150644 |
| 83 | kynurenine metabolic process (GO:0070189) | 2.95737489 |
| 84 | leukocyte tethering or rolling (GO:0050901) | 2.94941543 |
| 85 | negative regulation of muscle hypertrophy (GO:0014741) | 2.93106185 |
| 86 | activation of adenylate cyclase activity (GO:0007190) | 2.92464967 |
| 87 | apical protein localization (GO:0045176) | 2.91867826 |
| 88 | negative regulation of monooxygenase activity (GO:0032769) | 2.91507517 |
| 89 | response to amphetamine (GO:0001975) | 2.90198779 |
| 90 | L-fucose metabolic process (GO:0042354) | 2.89982723 |
| 91 | L-fucose catabolic process (GO:0042355) | 2.89982723 |
| 92 | fucose catabolic process (GO:0019317) | 2.89982723 |
| 93 | regulation of chemokine secretion (GO:0090196) | 2.89910867 |
| 94 | serotonin metabolic process (GO:0042428) | 2.88134631 |
| 95 | cGMP biosynthetic process (GO:0006182) | 2.84534776 |
| 96 | regulation of calcium-mediated signaling (GO:0050848) | 2.82806707 |
| 97 | adenosine metabolic process (GO:0046085) | 2.82335934 |
| 98 | glycosylceramide metabolic process (GO:0006677) | 2.78285971 |
| 99 | sleep (GO:0030431) | 2.77626439 |
| 100 | skeletal muscle tissue regeneration (GO:0043403) | 11.1088254 |
ACTG1P12 
